Zenas BioPharma, Inc. (ZBIO) EBITDA Margin (2024 - 2026)
Zenas BioPharma's EBITDA Margin came in at -10765.50% for Q2 2026.
Powered by 
Analysis
Zenas BioPharma, Inc. (ZBIO) EBITDA Margin (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Zenas BioPharma reported EBITDA Margin of -47554.20%, down 46294.23 percentage points year-over-year; for FY2025, it was -3830.01%, down 554.99 percentage points from FY2024.
- Going back by year, EBITDA Margin was -3275.02% in FY2024 (-3200.95 pp) and -74.07% in FY2023.
- The Q2 2026 figure represents the highest quarterly EBITDA Margin since Q1 2025.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,765.50% |
| Mar 31, 2025 | -373.07% |
| Dec 31, 2024 | -1,111.80% |
API Access
Zenas BioPharma, Inc. EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ZBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();